Literature DB >> 11085983

Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation.

A Alonso1, M Saxena, S Williams, T Mustelin.   

Abstract

The 21-kDa dual specific protein phosphatase VH1-related (VHR) is one of the smallest known phosphatases, and its function has remained obscure. We report that this enzyme is expressed in lymphoid cells and is not induced by T cell antigen receptor like other dual specificity phosphatases. Introduction of exogenous VHR into Jurkat T cells caused a marked decrease in the transcriptional activation of a nuclear factor of activated T cells and an activator protein-1-driven reporter gene in response to ligation of T cell antigen receptors. The inhibition was dose-dependent and was similar at different doses of anti-receptor antibody. Catalytically inactive VHR mutants caused an increase in gene activation, suggesting a role for endogenous VHR in this response. In contrast, the activation of a nuclear factor kappaB-driven reporter was not affected. The inhibitory effects of VHR were also seen at the level of the mitogen-activated kinases Erk1, Erk2, Jnk1, Jnk2, and on reporter genes that directly depend on these kinases, namely Elk, c-Jun, and activator protein-1. In contrast, p38 kinase activation was not affected by VHR, and p38-assisted gene activation was less sensitive. Our results suggest that VHR is a negative regulator of the Erk and Jnk pathways in T cells and, therefore, may play a role in aspects of T lymphocyte physiology that depend on these kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085983     DOI: 10.1074/jbc.M006497200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

2.  DUSP3 Genetic Deletion Confers M2-like Macrophage-Dependent Tolerance to Septic Shock.

Authors:  Pratibha Singh; Lien Dejager; Mathieu Amand; Emilie Theatre; Maud Vandereyken; Tinatin Zurashvili; Maneesh Singh; Matthias Mack; Steven Timmermans; Lucia Musumeci; Emmanuel Dejardin; Tomas Mustelin; Jo A Van Ginderachter; Michel Moutschen; Cécile Oury; Claude Libert; Souad Rahmouni
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

3.  Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis.

Authors:  Andrea Nören-Müller; Ivan Reis-Corrêa; Heino Prinz; Claudia Rosenbaum; Krishna Saxena; Harald J Schwalbe; Dietmar Vestweber; Guiseppe Cagna; Stefan Schunk; Oliver Schwarz; Hajo Schiewe; Herbert Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

4.  MAP kinases: differential activation following in vivo and ex vivo irradiation.

Authors:  Anirban Kumar Mitra; Rakesh Kumar Singh; Malini Krishna
Journal:  Mol Cell Biochem       Date:  2006-11-29       Impact factor: 3.396

5.  Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain.

Authors:  Kentaro Takagaki; Hiroshi Shima; Nobuhiro Tanuma; Miyuki Nomura; Takeshi Satoh; Masahiko Watanabe; Kunimi Kikuchi
Journal:  Mol Cell Biochem       Date:  2006-09-26       Impact factor: 3.396

Review 6.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

7.  Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.

Authors:  Timothy E Sweeney; Lindsay Braviak; Cristina M Tato; Purvesh Khatri
Journal:  Lancet Respir Med       Date:  2016-02-20       Impact factor: 30.700

Review 8.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

9.  Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes.

Authors:  Rinrada Luechapanichkul; Xianwen Chen; Hashem A Taha; Shubham Vyas; Xiaoyan Guan; Michael A Freitas; Christopher M Hadad; Dehua Pei
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

10.  Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Authors:  Shuangding Wu; Sofie Vossius; Souad Rahmouni; Ana V Miletic; Torkel Vang; Jesus Vazquez-Rodriguez; Fabio Cerignoli; Yutaka Arimura; Scott Williams; Tikva Hayes; Michel Moutschen; Stefan Vasile; Maurizio Pellecchia; Tomas Mustelin; Lutz Tautz
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.